Antifibrinolytic refers to a process, protein, or drug that does not allow for the breakdown of fibrin. If fibrin can not be destroyed, a clot remains. For a bleeding patient, the use of antifibrinolytic agents is beneficial. In a procoagulant state, the inability to break down a thrombus could be detrimental.
